| Product Code: ETC7383157 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of valganciclovir to Grenada in 2024 saw a notable shift in concentration, moving from very high concentration in 2023 to high concentration in 2024. The top exporting countries to Grenada for valganciclovir in 2024 were the USA, Barbados, UK, India, and Turkey. Despite a negative Compound Annual Growth Rate (CAGR) of -4.19% from 2020 to 2024, there was a significant decline in growth rate from 2023 to 2024 at -16.97%. These trends suggest a changing landscape in the import dynamics of valganciclovir to Grenada, with implications for market players and stakeholders.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Grenada Valganciclovir Market Overview |
3.1 Grenada Country Macro Economic Indicators |
3.2 Grenada Valganciclovir Market Revenues & Volume, 2021 & 2031F |
3.3 Grenada Valganciclovir Market - Industry Life Cycle |
3.4 Grenada Valganciclovir Market - Porter's Five Forces |
3.5 Grenada Valganciclovir Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Grenada Valganciclovir Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Grenada Valganciclovir Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cytomegalovirus (CMV) infections |
4.2.2 Growing awareness about the efficacy of valganciclovir in treating CMV |
4.2.3 Technological advancements leading to improved formulations or delivery methods |
4.3 Market Restraints |
4.3.1 High cost of valganciclovir treatment |
4.3.2 Stringent regulatory requirements for approval and distribution |
4.3.3 Potential side effects or adverse reactions associated with valganciclovir |
5 Grenada Valganciclovir Market Trends |
6 Grenada Valganciclovir Market, By Types |
6.1 Grenada Valganciclovir Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Grenada Valganciclovir Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Grenada Valganciclovir Market Revenues & Volume, By Powder, 2021- 2031F |
6.1.4 Grenada Valganciclovir Market Revenues & Volume, By Tablet, 2021- 2031F |
6.2 Grenada Valganciclovir Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Grenada Valganciclovir Market Revenues & Volume, By Adults, 2021- 2031F |
6.2.3 Grenada Valganciclovir Market Revenues & Volume, By Children, 2021- 2031F |
7 Grenada Valganciclovir Market Import-Export Trade Statistics |
7.1 Grenada Valganciclovir Market Export to Major Countries |
7.2 Grenada Valganciclovir Market Imports from Major Countries |
8 Grenada Valganciclovir Market Key Performance Indicators |
8.1 Patient adherence rate to valganciclovir treatment regimen |
8.2 Number of clinical trials investigating new applications or formulations of valganciclovir |
8.3 Rate of adoption of valganciclovir as a preferred treatment option among healthcare providers |
9 Grenada Valganciclovir Market - Opportunity Assessment |
9.1 Grenada Valganciclovir Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Grenada Valganciclovir Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Grenada Valganciclovir Market - Competitive Landscape |
10.1 Grenada Valganciclovir Market Revenue Share, By Companies, 2024 |
10.2 Grenada Valganciclovir Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |